RxSight, Inc.·4

Mar 13, 4:46 PM ET

Fountain Tamara 4

4 · RxSight, Inc. · Filed Mar 13, 2025

Insider Transaction Report

Form 4
Period: 2025-03-12
Transactions
  • Sale

    Common Stock

    2025-03-12$25.71/sh7,000$180,00224,793 total
Footnotes (2)
  • [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on December 11, 2024 by the Reporting Person.
  • [F2]Represents the weighted average share price of an aggregate total of 7,000 shares sold in the price range of $25.355 to $26.175 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

2 files